Merck EVP Maraldo reports stock and option holdings
Merck & Co., Inc. executive David R. Maraldo, EVP & President of Merck Manufacturing Division, filed an amended initial ownership report showing his current equity holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3/A
Rhea-AI Filing Summary
Merck & Co., Inc. executive David R. Maraldo, EVP & President of Merck Manufacturing Division, filed an amended initial ownership report showing his current equity holdings. He reports 17,819.434 shares of Merck common stock held directly and 8,359.140 shares held indirectly through a 401(k) plan. The filing also lists multiple stock options on Merck common stock with exercise prices between $73.73 and $129.22 per share that expire between 2031 and 2035, plus several restricted stock unit awards scheduled to vest in equal installments from 2024 through 2028. The report reflects holdings only and does not show new purchases or sales.
Insider Trade Summary
10 transactions reported
Mixed
10 txns
Insider
Maraldo David R.
Role
EVP & Pres. MMD
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock - 401(k) Plan | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 3,494 contracts (Direct);
Stock Option (Right to Buy) — 45,013 contracts (Direct);
Common Stock — 17,819.434 shares (Direct);
Common Stock - 401(k) Plan — 8,359.14 shares (Indirect, By 401 (k))
Footnotes (9)
- F1. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025, and 5/2/2026.
- F2. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- F3. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026, and, 4/30/2027.
- F4. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027, and, 4/29/2028.
- F5. The options became exercisable in equal installments in on 5/4/2022, 5/4/2023, and 5/4/2024.
- F6. The options became exercisable in equal installments on 5/3/2023, 5/3/2024, and 5/3/2025.
- F7. The options vest and become exercisable in equal installments on 5/2/2024, 5/2/2025, and 5/2/2026.
- F8. The options vest and become exercisable in equal installments on 4/30/2025, 4/30/2026, and 4/30/2027.
- F9. The options vest and become exercisable in equal installments on 4/29/2026, 4/29/2027, and 4/29/2028.
Key Figures
Direct common shares: 17,819.434 shares
401(k) common shares: 8,359.140 shares
Option grant (2035 expiry): 8,060 shares at $84.71
+5 more
8 metrics
Direct common shares
17,819.434 shares
Common Stock holdings following transaction
401(k) common shares
8,359.140 shares
Common Stock - 401(k) Plan holdings
Option grant (2035 expiry)
8,060 shares at $84.71
Stock Option (Right to Buy), expires 2035-04-28
Option grant (2034 expiry)
8,789 shares at $129.22
Stock Option (Right to Buy), expires 2034-04-29
Option grant (2031 expiry)
9,465 shares at $73.73
Stock Option (Right to Buy), expires 2031-05-03
RSU award (2028 expiry)
2,361 units
Restricted Stock Unit, expires 2028-04-29
RSU award (2027 expiry)
581 units
Restricted Stock Unit, expires 2027-04-30
RSU award (2026 expiry)
552 units
Restricted Stock Unit, expires 2026-05-02
Key Terms
Restricted Stock Unit, Stock Option (Right to Buy, 401(k) Plan, beneficial ownership
4 terms
Restricted Stock Unit financial
"security_title: "Restricted Stock Unit" with underlying Merck common stock"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option (Right to Buy financial
"security_title: "Stock Option (Right to Buy)" on Merck common stock"
401(k) Plan financial
"security_title: "Common Stock - 401(k) Plan" indicating indirect holdings"
A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.
beneficial ownership financial
"Form 3/A serves as an amended initial statement of beneficial ownership"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Merck (MRK) executive David R. Maraldo report in this Form 3/A?
David R. Maraldo reports his existing Merck equity holdings, including common stock, stock options, and restricted stock units. The filing is an amended initial ownership statement and lists positions rather than new purchase or sale transactions.
What restricted stock units (RSUs) are reported for Merck (MRK) executive David R. Maraldo?
He reports restricted stock units covering 552, 581 and 2,361 underlying Merck common shares. Footnotes state these RSUs vest and are distributed in three equal installments on specified dates between 2024 and 2028.
Does this Merck (MRK) Form 3/A show any insider buying or selling activity?
The filing categorizes entries as holdings, with zero buy or sell transactions in the transaction summary. It functions as a position snapshot, not a record of new open-market purchases, sales, or option exercises.
How do the vesting schedules work for David R. Maraldo’s Merck (MRK) RSUs and options?
Footnotes explain that the RSUs and options vest or become exercisable in three equal installments on dates such as 5/2/2024–5/2/2026, 4/30/2025–4/30/2027, and 4/29/2026–4/29/2028. Each RSU represents a contingent right to one Merck share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates